Comparative analysis of the PCA3 gene expression in sediments and exosomes isolated from urine
Open Access
- 30 September 2017
- journal article
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 13 (3) , 54-60
Abstract
Introduction. Prostate cancer (PCa) is one of the common oncological diseases in men. Expression of the PCA3 gene in urine is currently used as a molecular genetic marker of PCa.Objective: to comparative analysis of the PCA3 expression in urine sediments and exosomes for the determination of the biomaterial, which allows detecting the PCA3 expression in more efficient manner.Materials and methods. The 12 patients with different stages of PCa and 8 control samples were examined.Results. The diagnostic accuracy of the PCA3 gene expression analysis in this cohort exceeded 90 %. We had not obtained significant differences in the sensitivity and specificity of the PCA3 hyperexpression in the urine sediments compared with exosomes. This result indicates in favor to using urine sediment for the PCA3 analysis as a biomaterial with less time-consuming sample preparation, although the possible advantage of exosomes for the analysis of the expression marker panels requires further studies.Keywords
This publication has 24 references indexed in Scilit:
- Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyJournal of Urology, 2017
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk ScoreEuropean Urology, 2016
- Test urinaire PCA3 et diagnostic du cancer prostatique : étude à partir de 1015 patientsProgrès en Urologie, 2015
- Processing of voided urine for prostate cancer RNA biomarker analysisThe Prostate, 2015
- Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate BiopsyJournal of Urology, 2014
- Prostate Cancer Biomarker Profiles in Urinary Sediments and ExosomesJournal of Urology, 2014
- PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experienceUrologic Oncology: Seminars and Original Investigations, 2013
- Comparative Effectiveness Review: Prostate Cancer Antigen 3 Testing for the Diagnosis and Management of Prostate CancerJournal of Urology, 2013
- Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?Urology, 2013
- Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patientsThe Prostate, 2012